Global Thrombin Market Size, Growth, Analysis, Forecast: By Product: Bovine Thrombin, Human Thrombin, Recombinant Thrombin; By Dosage Form: Powder Form, Solution Form; By End User: Hospitals, Diagnostic Centre and Clinics, Academics and Research Institutes, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2023-2031

Global Thrombin Market Outlook

The global thrombin market attained a value of more than USD 578.5 million in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 4.22% to reach over USD 741.3 million by 2027.

 

Global Thrombin Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Witness a Considerable Growth of the Thrombin Industry

North America holds a considerable share of the thrombin industry owing to the increasing prevalence of road accidents in the region. The growing incidences of trauma cases are surging the demand for thrombin, hence driving the market growth. The increasing prevalence of genetically inherited blood disorders such as inherited thrombophilia, especially among the Caucasian and Scandinavian population, is surging the risk for thrombosis, which is further adding to the growth of the industry.

Moreover, the rising disposable income of the population and well established healthcare infrastructure are providing lucrative growth opportunities to the thrombin industry. The growing presence of leading companies like Pfizer inc. and Johnson & Johnson Services Inc., among others, in the region are increasing research and development (R&D) activities of thrombin, which is providing further impetus to the growth of the market.

 

Thrombin: Market Segmentation

Thrombin refers to a naturally occurring enzyme that converts fibrinogen into fibrin to enable the clotting of blood. It is usually derived from prothrombin and is typically used as a topical haemostatic agent. Moreover, thrombin is utilised in near larger vessels to prevent disseminated intravascular coagulation (DIC) and death in surgeries.

 

Global Thrombin Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major products of thrombin are:

  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin

Based on dosage form, the market is bifurcated into:

  • Powder Form
  • Solution Form

By end user, the market is divided into:

  • Hospitals
  • Diagnostics Centre and Clinics
  • Academics and Research Institutes

The EMR report looks into the regional markets of thrombin like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Thrombin Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Haemophilia to Bolster the Market Growth of Thrombin

The rising prevalence of haemophilia in both developed and developing countries is surging the utilisation of thrombin in its treatment, which is fuelling the market growth. The extensive use of thrombin in the healthcare sector owing to the rising incidences of surgical haemostatic is driving the market growth. As the risk of blood clotting during thrombin is very high, the use of thrombin as a haemostatic ancillary is growing, thereby augmenting the industry growth.

The development of thrombin from alternative sources owing to the increasing bleeding complications of bovine thrombin is expected to propel the industry growth. With the growing availability of recombinant and human thrombin, their popularity is increasingly growing among surgeons to prevent the risk of antigenicity, which is predicted to bolster the industry growth. The increasing approvals of innovative thrombin by health organisations such as the Food and Drug Administration (FDA) is estimated to significantly contribute to the growth of the market in the forecast period.

 

Key Industry Players in the Global Thrombin Market

The report presents a detailed analysis of the following key players in the global thrombin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc.
  • Johnson and Johnson Services Inc.
  • Baxter International, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Japan Blood Products Organization
  • Mochida Pharmaceutical Co., Ltd
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Dosage Form
  • End User
  • Region
Breakup by Product
  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin
Breakup by Dosage Form
  • Powder Form
  • Solution Form
Breakup by End User
  • Hospitals
  • Diagnostic Centre and Clinics
  • Academics and Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Johnson and Johnson
  • Baxter International, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Japan Blood Products Organization
  • Mochida Pharmaceutical Co., Ltd
  • Haematologic Technologies Inc.
  • GE Healthcare
  • Hualan Biological
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Thrombin Market Overview 

    3.1    Global Thrombin Market Historical Value (2016-2022) 
    3.2    Global Thrombin Market Forecast Value (2023-2031)
4    Global Thrombin Market Landscape
    4.1    Global Thrombin Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Thrombin Product Landscape
        4.2.1    Analysis by Product
        4.2.2    Analysis by Dosage Form
        4.2.3    Analysis by End User
5    Global Thrombin Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Thrombin Market Segmentation 
    6.1    Global Thrombin Market by Product 
        6.1.1    Market Overview                                     
        6.1.2    Bovine Thrombin
        6.1.3    Human Thrombin
        6.1.4    Recombinant Thrombin
    6.2    Global Thrombin Market by Dosage Form
        6.2.1    Market Overview
        6.2.2    Powder Form
        6.2.3    Solution Form
    6.3    Global Thrombin Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Diagnostic Centre and Clinics
        6.3.4    Academics and Research Institutes
        6.3.5    Others
    6.4    Global Thrombin Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Thrombin Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Thrombin Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Thrombin Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Thrombin Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Thrombin Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Pfizer Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Johnson and Johnson
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Baxter International, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Shanghai RAAS Blood Products Co., Ltd.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Japan Blood Products Organization
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Mochida Pharmaceutical Co., Ltd
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Haematologic Technologies Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    GE Healthcare
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Hualan Biological
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
18    Global Thrombin Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2021, the global thrombin market attained a value of more than USD 578.5 million.

The market is estimated to grow at a CAGR of 4.22% between 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach above USD 741.3 million by 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the market include the growing incidences of road accidents and increasing prevalence of haemophilia.

The growing R&D activities in the healthcare industry in the emerging economies is expected to be a key trend guiding the growth of the industry.

The major products available in the market are bovine thrombin, human thrombin, and recombinant thrombin.

The different forms of dosage in the market are powder form and solution form.

The different end users are hospitals, diagnostics centre and clinics, and academics and research institutes.

The major players in the industry are Pfizer Inc., Johnson and Johnson Services Inc., Baxter International, Inc., Shanghai RAAS Blood Products Co., Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co., Ltd, among others.

Analyst Review

The global thrombin market attained a value of more than USD 578.5 million in 2021, driven by the rising cases of haemophilia. Aided by the technological advancements in the healthcare industry in the emerging economies, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4.22%. The market is projected to reach over USD 741.3 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the market is divided into bovine thrombin, human thrombin, and recombinant thrombin. On the basis of dosage form, the market is divided into powder form and solution form. By end user, the market has been segmented into hospitals, diagnostics centre and clinics, and academics and research institutes. The major regional markets for thrombin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Johnson and Johnson Services Inc., Baxter International, Inc., Shanghai RAAS Blood Products Co., Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co., Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER